Literature DB >> 21992124

Hepatocellular carcinoma.

Hashem B El-Serag1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21992124     DOI： 10.1056/NEJMra1001683

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1699 in total

1.  Socioeconomic status and hepatocellular carcinoma in the United States.

Authors:  Fatma M Shebl; David E Capo-Ramos; Barry I Graubard; Katherine A McGlynn; Sean F Altekruse
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-05       Impact factor: 4.254

2.  Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.

Authors:  Daniel L Motola; Peter Caravan; Raymond T Chung; Bryan C Fuchs
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

3.  The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.

Authors:  Surong Hu; Lianying Zhao; Jingting Yang; Miao Hu
Journal:  Tumour Biol       Date:  2013-12-11

4.  Single measurement of hemoglobin predicts outcome of HCC patients.

Authors:  Fabian Finkelmeier; Dominik Bettinger; Verena Köberle; Michael Schultheiß; Stefan Zeuzem; Bernd Kronenberger; Albrecht Piiper; Oliver Waidmann
Journal:  Med Oncol       Date:  2013-12-11       Impact factor: 3.064

5.  Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy.

Authors:  Neil Mehta; Jennifer L Dodge; Aparna Goel; John Paul Roberts; Ryutaro Hirose; Francis Y Yao
Journal:  Liver Transpl       Date:  2013-12       Impact factor: 5.799

6.  A proteomics-based investigation on the anticancer activity of alisertib, an Aurora kinase A inhibitor, in hepatocellular carcinoma Hep3B cells.

Authors:  Qiaohua Zhu; Meihua Luo; Chengyu Zhou; Zhiwei Zhou; Zhixu He; Xinfa Yu; Shufeng Zhou
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

Review 7.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

8.  Screening for hepatocellular carcinoma by Egyptian physicians.

Authors:  Sahar M Hassany; Ehab F Abdou Moustafa; Mohamed El Taher; Afaf Adel Abdeltwab; Hubert E Blum
Journal:  World J Gastrointest Oncol       Date:  2015-09-15

9.  Targeted sequencing of cancer-associated genes in hepatocellular carcinoma using next-generation sequencing.

Authors:  Asahiro Morishita; Hisakazu Iwama; Shintaro Fujihara; Miwako Watanabe; Koji Fujita; Tomoko Tadokoro; Kyoko Ohura; Taiga Chiyo; Teppei Sakamoto; Shima Mimura; Takako Nomura; Joji Tani; Hirohito Yoneyama; Keiichi Okano; Yasuyuki Suzuki; Takashi Himoto; Tsutomu Masaki
Journal:  Oncol Lett       Date:  2017-11-02       Impact factor: 2.967

10.  miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.

Authors:  Caifeng Liu; Jun Li; Wei Wang; Xingyang Zhong; Feng Xu; Junhua Lu
Journal:  Cell Cycle       Date:  2020-04-14       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.